Nexpep’s development of Nexvax2 has attracted global attention today with the publication of landmark research in Science Translational Medicine: “Comprehensive, Quantitative Mapping of T Cell Epitopes in Gluten in Celiac Disease”, by Jason A. Tye-Din et al.

[Read the rest of this article...]

Medical reporter Cathryn Delude from the LA Times (“New hope for celiac disease sufferers?”, December 21^st 2009) talks with Nexpep CEO Dr Robert Anderson about Nexvax2, the coeliac vaccine currently in a clinical trial in Australia.

[Read the rest of this article...]

Dr Bana Jabri, a world leading American coeliac disease researcher and winner of the prestigious 2009 Warren Prize for Excellence in Basic Research joins Nexpep as Senior Scientific Advisor.

[Read the rest of this article...]

ABC national medical reporter Sophie Scott reports on the world-first trial of a vaccine for coeliac disease and what it may mean to sufferers of this common condition.

[Read the rest of this article...]